ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced that Vivek Ahuja, Vice President, Global Pharmacovigilance at ArisGlobal, will present a session at the January 22nd closed-door “Lunch and Learn” series, held at the DIA Pharmacovigilance and Risk Management Conference, scheduled for January 23-25, 2018 in Washington, D.C. “How Automation Can Deliver the Holy Grail in Safety"
MIAMI, FLORIDA. January 11, 2018, 2017 -- ArisGlobal, a leading ...
Changing leadership will rapidly advance company’s focus on LifeSphere® cognitive ...
LifeSphere Safety MultiVigilance is the first pharmacovigilance solution (version 7.4.1.1-HF1) to have successfully completed E2B R3 testing with the XCOMP EudraVigilance system. Organizations using this same tested version should contact the European Medicines Agency and confirm that step 5b can be performed by themselves without the need for confirmation by the Agency.
ArisGlobal today announced that a top-five global life sciences company based in the U.S. selected ArisGlobal’s LifeSphere Safety cloud solution suite as its enterprise-level pharmacovigilance and drug safety software platform to enhance their capabilities to deliver health and wellness outcomes to waiting patients around the globe and across all business units: pharmaceutical, medical devices and consumer packaged goods.
CHICAGO, IL. APRIL 7, 2017--ArisGlobal, LLC, a global leader in ...
Self-service capabilities deliver improved compliance, process efficiency and operational effectiveness ...
Multi-tenant cloud solution acts as front end to any safety database and integrates with mobile-based applications to automate and standardize the case intake process for reports received from the field, reducing costs for greater ROI
Life science organizations can be utilizing the platform’s full clinical ...
New Multi-Tenant Cloud Platform Gives Life Science Organizations Complete Clinical ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
